Skip to content

Exelixis EXEL Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Eli Lilly logo
Eli LillyLLY
$4.09B+78.5%
Pfizer logo
PfizerPFE
$14.2B+6.8%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$1.8M+5.3%
Incyte logo
IncyteINCY
$126.59M-27.9%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$28.27M-49.2%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$229K-34.9%

Other financials

Income statement

See full
Revenue$610.8M+10.0%
Gross profit$590.9M+10.2%
Operating income$251.3M+34.5%
Net income$210.5M+31.9%
EPS (diluted)$0.79+43.6%

Balance sheet

See full
Cash & equivalents$226.2M+23.1%
Total debt$169.5M-9.4%
Total equity$1.9B-9.2%
Total assets$2.6B-8.6%

Cash flow

See full
Operating cash flow$251.8M+19.1%
CapEx$1.5M-48.9%
Free cash flow$250.3M+20.1%

Valuation

See full
Market cap$13.05B+10.1%
Enterprise value$12.99B+9.5%
P/E15.7×-2.8×
P/S5.5×+0.3×

Profitability

See full
Gross margin96.4%-0.3pp
Operating margin39.4%+6.3pp
Net margin35.1%+7.1pp
FCF margin38.6%+2.9pp

Returns & leverage

See full
Return on equity41%+10.8pp
Debt / equity0.1×0.0×
Current ratio3.3×-0.2×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exelixis's other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exelixis's other non-current liabilities?
Exelixis (EXEL) reported other non-current liabilities of $117.33M in Q1 2026.
How has Exelixis's other non-current liabilities changed year-over-year?
Exelixis's other non-current liabilities decreased by 2.2% year-over-year, from $120M to $117.33M.
What is the long-term trend for Exelixis's other non-current liabilities?
Over 5 years (2020 to 2025), Exelixis's other non-current liabilities has grown at a 170.5% compound annual growth rate (CAGR), from $721K to $104.42M.
What does other non-current liabilities mean?
Miscellaneous long-term debts and obligations that are not classified elsewhere on the balance sheet.
How do you interpret other non-current liabilities?
Significant changes should be investigated via footnotes to determine if they represent one-time adjustments or structural changes in long-term risk.
How does other non-current liabilities compare across companies?
Varies widely by company; often contains unique items related to specific tax positions or long-term legal settlements.